Saturday 17 October 2026
Export SMTI’s income statement to Excel — free account
Sanara MedTech Inc.
SMTI Healthcare Medical Instruments & Supplies
Sanara MedTech Inc.’s revenue for fiscal 2025 (year ended December 2025) was $103.1 million, up 19.0% from fiscal 2024. In the quarter to June 2026, revenue grew 9.04%, EPS grew 78.3%, free cash flow grew 131.3% and total debt rose 5.11%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
33.14
1.95
−5.56%
Follow SMTI
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 26.93 | 37.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
7 | 4 | 7 | 2 | 3 | 5 | 2 | 4 | 4 | 4 |
P/S ratio |
1.08 | 1.06 | 0.71 | 2.92 | 18.36 | 8.99 | 6.99 | 5.22 | 3.25 | 1.95 |
Altman Z-Score |
(26.97) | (24.71) | 9.37 | 4.94 | 42.09 | 20.87 | 10.87 | 7.22 | 4.11 | 2.35 |
P/FCF ratio |
0.00 | 0.00 | 12.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 92.62 |
Altman Z″-Score (non-manufacturers) |
(70.06) | (68.70) | 3.83 | 2.65 | (3.61) | 5.69 | 0.48 | 0.44 | 0.87 | (1.26) |
Beneish M-Score |
(3.76) | (1.44) | (3.53) | (2.26) | (1.50) | (2.50) | (1.24) | (2.40) | (2.51) | (3.22) |
P/Operating CF |
10.85 | 23.73 | 39.59 | (41.20) | (484.14) | (121.59) | (496.49) | (399.41) | 302.22 | 51.04 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 49.00 | 7.20 | 7.68 | 7.60 | 7.24 | 33.96 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 104.35 | 8.53 | 48.46 | 0.00 | 23.81 | 0.00 |
EV/Sales |
1.18 | 1.18 | 0.86 | 2.49 | 18.36 | 8.23 | 6.81 | 5.29 | 3.43 | 2.25 |
EV/EBITDA |
1.18 | 41.85 | 27.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.53 | 20.09 |
EV/Operating CF |
(1.10) | (57.04) | 14.56 | (13.54) | (70.94) | (41.28) | (56.18) | (105.83) | (12,496.15) | 34.14 |
EV/FCF |
(1.09) | (43.62) | 15.39 | (7.50) | (50.40) | (35.71) | (49.54) | (83.57) | (348.62) | 106.57 |
Quick Ratio |
1.17 | 0.61 | 1.07 | 3.01 | 0.77 | 3.59 | 1.25 | 0.99 | 1.85 | 1.53 |
Current Ratio |
1.43 | 0.96 | 1.51 | 3.35 | 1.27 | 4.09 | 1.61 | 1.38 | 2.18 | 1.80 |
Net Debt/EBITDA |
(3.71) | 3.66 | (0.66) | 1.91 | (0.01) | 2.69 | 0.80 | (8.50) | 2.32 | 2.55 |
Debt/Assets |
74.52% | 54.11% | 0.00% | 14.55% | 4.90% | 1.17% | 1.34% | 13.12% | 34.84% | 63.02% |
Debt/Equity |
(3.82) | 11.71 | 0.00 | 0.25 | 0.08 | 0.01 | 0.02 | 0.22 | 0.79 | 7.75 |
Asset Turnover |
3.09 | 2.87 | 4.47 | 1.83 | 1.49 | 1.04 | 0.94 | 0.96 | 1.07 | 1.28 |
Operating CF/Net income |
(0.60) | (0.73) | 11.70 | 0.77 | 0.93 | 0.61 | 0.70 | 0.75 | 0.00 | (0.18) |
Capex/Depreciation |
(0.05) | (1.07) | (0.49) | (14.21) | (5.64) | (1.26) | (0.31) | (0.07) | (0.04) | (1.09) |
Interest Coverage |
(1.56) | 0.95 | 3.50 | (25.87) | (437.79) | (10,537.43) | (43.97) | (8.86) | 0.40 | 1.08 |
| 40.41% | (18.92%) | (0.77%) | 35.72% | (1,007.96%) | (44.02%) | (22.09%) | (9.97%) | (23.15%) | (167.53%) | |
| (38.03%) | 8.76% | 2.25% | (43.88%) | (41.60%) | (34.28%) | (16.29%) | (6.38%) | (11.93%) | (46.65%) | |
ROIC |
(47.04%) | 8.97% | 32.30% | (122.50%) | (53.64%) | (38.66%) | (23.30%) | (5.36%) | 1.46% | 12.92% |
Return on Tangible Assets |
(106.44%) | (1,308.16%) | 7.53% | (43.83%) | (268.75%) | (39.19%) | (86.03%) | (66.24%) | (52.39%) | (244.35%) |
Average Days of Receivables |
52.64 | 48.43 | 42.51 | 41.42 | 53.08 | 45.20 | 55.76 | 47.92 | 52.43 | 42.47 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.26% | 2.31% | 7.34% | 6.36% | 3.26% | 4.92% |
Selling, General and Administrative Expense of Revenue |
86.51% | 83.67% | 87.09% | 111.05% | 119.80% | 116.19% | 100.29% | 87.70% | 82.69% | 76.34% |
Intangible Assets out of Total Assets |
0.06 | 0.05 | 0.00 | 0.13 | 0.32 | 0.13 | 0.58 | 0.66 | 0.31 | 0.30 |
Share Based Compensation of Revenue |
1.00% | 0.96% | 0.17% | 0.00% | 9.00% | 11.05% | 5.90% | 5.30% | 5.12% | 5.00% |
Graham Net Nets |
(0.14) | (0.01) | 0.09 | 0.12 | 0.00 | 0.08 | 0.00 | (0.03) | (0.06) | (0.17) |
Graham Number |
0.00 | 0.00 | 0.00 | 8.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(40.45%) | 3.71% | 2.70% | (8.86%) | (1.58%) | (3.65%) | (2.48%) | (1.27%) | (3.43%) | (18.63%) |
Free Cash Flow Yield |
(99.89%) | (2.55%) | 7.88% | (11.40%) | (1.98%) | (2.57%) | (1.97%) | (1.21%) | (0.30%) | 1.08% |
Revenue per Share |
5.07 | 5.66 | 4.24 | 5.52 | 2.72 | 3.29 | 5.80 | 7.85 | 10.22 | 11.96 |
Operating CF per Share |
0.38 | (0.13) | 0.25 | (1.02) | (0.70) | (0.66) | (0.70) | (0.39) | 0.00 | 0.79 |
Capex per Share |
0.00 | (0.08) | (0.01) | (0.80) | (0.29) | (0.10) | (0.09) | (0.03) | (0.03) | (0.53) |
Free Cash Flow per Share |
0.37 | (0.20) | 0.24 | (1.82) | (0.99) | (0.76) | (0.80) | (0.42) | (0.03) | 0.25 |
Cash per Share |
0.77 | 0.42 | 0.09 | 3.10 | 0.08 | 2.54 | 1.13 | 0.62 | 1.87 | 1.92 |
Shareholders Equity per Share |
(0.39) | 0.09 | 0.28 | 3.00 | 1.02 | 4.11 | 5.28 | 5.39 | 4.59 | 0.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.39) | 0.09 | 0.28 | 3.00 | 1.02 | 4.11 | 5.28 | 5.39 | 4.59 | 0.69 |
Free Cash Flow |
0.41 | (0.23) | 0.49 | (3.87) | (5.68) | (5.56) | (6.30) | (3.51) | (0.25) | 2.20 |
Working Capital |
0.60 | (0.08) | 0.57 | 6.22 | 0.94 | 18.59 | 7.81 | 5.24 | 18.02 | 14.92 |
Capital Expenditures |
0.00 | (0.09) | (0.03) | (1.70) | (1.64) | (0.75) | (0.75) | (0.26) | (0.23) | (4.59) |
Net Current Asset Value |
(0.60) | (0.08) | 0.57 | 4.13 | 0.50 | 18.36 | 1.30 | (10.28) | (15.87) | (33.47) |
EV/EBIT |
1.18 | 76.29 | 35.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 236.26 | 31.72 |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.14 | 0.11 | 0.03 | 0.02 | 0.00 | 0.00 | 0.04 |
Price to Operating Income |
1.08 | 68.71 | 29.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 223.76 | 27.56 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.75 | 1.28 | 3.03 | 0.59 | 0.43 | 0.37 | 1.67 | 2.93 | 11.87 | 9.25 |
Cash ROIC |
20.02% | (12.79%) | 64.11% | (26.48%) | (83.80%) | (11.30%) | (12.23%) | (5.91%) | (0.30%) | 3.21% |
Accounts Receivable Turnover |
8.84 | 7.73 | 9.45 | 9.98 | 8.65 | 9.19 | 9.17 | 8.37 | 8.26 | 8.44 |
Accounts Payable Turnover |
3.28 | 2.61 | 3.56 | 4.04 | 3.59 | 4.25 | 6.30 | 4.58 | 4.61 | 3.89 |
Inventory Turnover |
2.49 | 1.52 | 1.45 | 2.00 | 1.71 | 1.45 | 2.27 | 1.90 | 2.18 | 2.24 |
Average Days of Payables |
128.38 | 129.29 | 82.63 | 122.60 | 111.72 | 93.81 | 81.87 | 93.05 | 68.64 | 113.50 |
Days of Inventory on Hand |
134.81 | 322.16 | 199.31 | 225.31 | 259.27 | 323.47 | 203.65 | 219.27 | 123.45 | 191.63 |
Average Receivables |
0.62 | 0.82 | 0.93 | 1.18 | 1.80 | 2.63 | 5.00 | 7.77 | 10.49 | 12.22 |
Average Payables |
0.29 | 0.31 | 0.24 | 0.30 | 0.45 | 0.54 | 1.01 | 1.71 | 1.77 | 1.93 |
Average Inventory |
0.38 | 0.53 | 0.59 | 0.61 | 0.95 | 1.60 | 2.80 | 4.13 | 3.74 | 3.35 |
Average Assets |
1.78 | 2.19 | 1.96 | 6.41 | 10.47 | 23.11 | 48.72 | 67.45 | 80.98 | 80.52 |
Average Common Equity |
(1.68) | (1.02) | (5.77) | (7.88) | 0.43 | 18.00 | 35.94 | 43.15 | 41.75 | 22.42 |
Columns are period end dates